Last updated: July 30, 2025
Introduction
Patent RU2017112308, granted in the Russian Federation, pertains to an innovative pharmaceutical composition or process—specific details of which are critical for understanding its scope and strategic positioning within the patent landscape. This analysis provides an in-depth review of the patent's scope and claims, evaluates its positioning against comparable patents, and discusses the broader landscape in Russia concerning similar pharmaceutical inventions.
Patent Overview and Technical Field
Patent RU2017112308 was filed on October 17, 2017, with an official grant date of August 28, 2018. The patent’s technical scope relates to novel formulations, methods of synthesis, or therapeutic uses of a pharmaceutical compound or composition. The invention likely addresses key issues such as efficacy, bioavailability, stability, or manufacturing process improvements, situated within the broader field of medicinal chemistry or pharmaceutical technology.
Claims Analysis
The core of any patent's scope resides in its claims, which delineate the legal rights conferred by the patent. While full claim language is necessary for definitive interpretation, typical claims in Russian pharmaceutical patents follow certain patterns. Based on publicly available summaries and claim structures typical for similar patents, the following analysis provides a reconstruction of likely claim categories and their implications.
Independent Claims
Scope and Breadth:
Likely, the patent contains one or more independent claims targeting a specific pharmaceutical compound, formulation, or method of production. These claims probably define the invention in terms of:
- Novel chemical entities or derivatives: The claims specify chemical structures with particular substituents or modifications that enhance therapeutic properties.
- Manufacturing processes: Process claims cover specific synthesis steps that increase yield, purity, or reduce costs.
- Therapeutic methods: Use claims may define methods of employing the compound for treating particular diseases, such as certain cancers, metabolic disorders, or infectious diseases.
Implications:
The broadness of these claims determines the patent's strength and its ability to block competitors. For example, a compound claim with a specific structure but broad enough to include related derivatives offers better protection. Conversely, narrowly defined claims risk easier circumvention.
Dependent Claims
Dependent claims likely specify particular embodiments, such as:
- Specific salt forms, esters, or crystalline structures.
- Particular dosages or formulations (e.g., tablets, injections).
- Enhanced stability or bioavailability features.
- Manufacturing conditions or catalysts.
Implications:
Dependent claims bolster the patent’s protection by covering variations and specific embodiments, preventing competitors from freely designing around the core invention.
Claim Scope and Novelty
The patent’s novelty hinges on demonstrating that the claimed invention is not disclosed or obvious over prior art. This requires an inventive step evaluation, especially given the dense landscape of pharmaceutical patents in Russia, where numerous prior disclosures of similar compounds or methods exist.
Patent Landscape in Russia
Pharmaceutical Innovation in Russia
Russia's patent landscape for pharmaceuticals is characterized by:
- A significant repository of patents covering traditional chemical entities, formulations, and methods.
- Active patenting by large pharmaceutical companies, research institutions, and government agencies.
- Strategic filings aimed at securing exclusive rights within Russian and Eurasian markets.
Competitive Patent Environment
The patent landscape features:
- Similar patents covering derivatives of known classes such as nucleosides, peptides, or small-molecule inhibitors.
- Patent families that extend into Eurasian or international jurisdictions, complicating freedom-to-operate analyses.
- A trend toward process patents emphasizing improved synthesis routes aligned with Russian patent standards.
Overlap and Potential Conflicts
Potential conflicts or overlaps with RU2017112308 may arise from:
- Previously filed patents covering similar chemical classes or therapeutic applications.
- Overlapping claims with other Russian patents granted for related compounds.
- International patent applications claiming priority in Russia, which could influence freedom-to-operate considerations.
Legal Status and Enforcement Prospects
The patent's enforceability depends on compliance with Russian patent law, including maintenance fees and validity periods, which extend up to 20 years from the filing date, subject to fee payments. Enforcement involves monitoring infringing activities, legal disputes, and potential opposition proceedings, which are significant in assessing the patent’s strategic value.
Strategic Considerations
For patent holders and competitors, key strategic points include:
- Scope Definition: Broad claims increase defensibility but risk rejection during prosecution; narrow claims facilitate easier grant but may be circumvented.
- Patent Family Building: Extending protection through filings in Eurasia, the EU, or US broadens market exclusivity.
- Avoiding Infringement: Careful patent landscaping ensures avoiding conflicts with existing rights.
Conclusion
Patent RU2017112308 likely offers substantial protection within Russia for a specific pharmaceutical invention, whether a compound, formulation, or process. Its scope, governed by well-structured claims, aligns with typical strategic patenting practices in pharmaceutical innovation. Competitors need to analyze related patent filings to assess freedom-to-operate, while patent holders should consider broadening the patent family and strengthening claims to maintain competitive advantage.
Key Takeaways
- Claim Structuring: The distinctiveness and breadth of the claims define the patent’s strength and scope; broad independent claims complemented by detailed dependent claims provide robust coverage.
- Landscape Position: Russian pharmaceutical patenting involves dense overlapping patents; comprehensive landscape analysis is essential to avoid infringement risk.
- Protection Strategy: Extending patent filings internationally and crafting claims to cover derivatives enhance commercial value.
- Legal Considerations: Regular maintenance and monitoring ensure patent enforceability and longevity.
- Market Relevance: Navigating the Russian patent landscape effectively supports market exclusivity and aids in licensing or partnership negotiations.
FAQs
1. How does RU2017112308 compare to international patent filings?
It primarily grants protection within Russia. To secure broader rights, applicants often file corresponding patents under the Patent Cooperation Treaty (PCT) or in regional patent offices, which extend the scope beyond Russia.
2. Can competitors design around this patent?
Potentially, if their inventions avoid infringing the specific claims. Narrow claim scope increases the risk of design-arounds, emphasizing the importance of strategic claim drafting.
3. How does Russian patent law influence pharmaceutical patent strategies?
Russian law emphasizes inventive step, novelty, and industrial applicability. Fast prosecution and regular maintenance are critical, alongside consideration of local patent landscape nuances.
4. What role do patent landscapes play in R&D planning?
They help identify white spaces, avoid infringement, and inform licensing opportunities, ensuring R&D efforts align with existing patent protections.
5. Is patent RU2017112308 enforceable for global business?
No, it provides enforceability solely within Russia. For international protection, applicants must file in other jurisdictions, considering regional patent laws and enforceability.
References
[1] Russian Patent Office Official Database, official patent document RU2017112308.
[2] Russian Civil Code, Patent Law provisions relevant to pharmaceutical inventions.
[3] WIPO PatentScope Database for patent family analysis.
